New quality assurance program integrating “modern radiotherapy” within the German Hodgkin Study Group-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

New quality assurance program integrating “modern radiotherapy” within the German Hodgkin Study Group

Published:2016-09-27 Issue:2 Volume:193 Page:100-108
ISSN:0179-7158
Container-title:Strahlentherapie und Onkologie
language:en
Short-container-title:Strahlenther Onkol

Author:

Kriz J.,Baues C.,Engenhart-Cabillic R.,Haverkamp U.,Herfarth K.,Lukas P.,Schmidberger H.,Marnitz-Schulze S.,Fuchs M.,Engert A.,Eich H. T.

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Radiology Nuclear Medicine and imaging

Link

http://link.springer.com/content/pdf/10.1007/s00066-016-1048-y.pdf

Reference17 articles.

1. Eich HT, Diehl V, Gorgen H, Pabst T, Markova J, Debus J et al (2010) Intensified chemotherapy and dose-reduced involved-field radiotherapy in patients with early unfavorable Hodgkin’s lymphoma: final analysis of the German Hodgkin Study Group HD11 trial. J Clin Oncol 28:4199–4206

2. Engert A, Plutschow A, Eich HT, Lohri A, Dorken B, Borchmann P et al (2010) Reduced treatment intensity in patients with early-stage Hodgkin’s lymphoma. N Engl J Med 363:640–652

3. Engert A, Haverkamp H, Kobe C, Markova J, Renner C, Ho A et al (2012) Reduced intensity of chemotherapy and PET-giuded radiotherapy in patients with advanced stage Hodgkin lymphoma: an open-label, randomised phase 3 trial. Lancet 379:1791–1799

4. Engert A, Schiller P, Josting A et al (2003) Involved-field radiotherapy is equally effective and less toxic compared with extended-field radiotherapy after four cycles of chemotherapy in patients with earlystage unfavorable Hodgkin’s lymphoma: results of the HD8 trial of the German Hodgkin’s Lymphoma Study Group. J Clin Oncol 21:3601–3608

5. Girinsky T, van der Maazen R, Specht L et al (2006) Involved-node radiotherapy (INRT) in patients with early Hodgkin lymphoma: concepts and guidelines. Radiother Oncol 79:270–277

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Quality Control Study on Involved Node Radiation Therapy in the European Organisation for Research and Treatment of Cancer/Lymphoma Study Association/Fondazione Italiana Linfomi H10 Trial on Stages I and II Hodgkin Lymphoma: Lessons Learned;International Journal of Radiation Oncology*Biology*Physics;2023-11

2. Risk analysis for radiotherapy at the Universitätsklinikum Erlangen;Zeitschrift für Medizinische Physik;2022-08

3. Implementing a new scale for failure mode and effects analysis (FMEA) for risk analysis in a radiation oncology department;Strahlentherapie und Onkologie;2020-09-19

4. Patterns of failure of diffuse large B‑cell lymphoma patients after involved-site radiotherapy;Strahlentherapie und Onkologie;2017-07-26

5. Radiation Therapy in Hodgkin’s Lymphoma;Radiation Oncology;2017

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3